Mary J Annino

Title: Mary J Annino: Innovator in Glycated Hemoglobin Testing

Introduction

Mary J Annino is a notable inventor based in Arlington Heights, IL (US). She has made significant contributions to the field of medical diagnostics, particularly in the rapid determination of glycated hemoglobin. With a total of 2 patents to her name, her work has the potential to enhance diabetes management and patient care.

Latest Patents

Mary J Annino's latest patents include innovative methods and reagents for the rapid determination of glycated hemoglobin. The first patent describes a rapid, continuous test that utilizes a non-equilibrium affinity binding method. Agarose beads derivatized with 3-aminophenylboronic acid specifically bind glycated hemoglobin. This solid phase is incorporated into a sample processor card, which is modified to mix and separate the test solution from the solid phase prior to absorbance readings. Two absorbance readings are taken on the test solution: one immediately after mixing the reagent/diluent with the specimen, and another after a significant amount of binding has occurred. A linear correlation between total glycated hemoglobin and hemoglobin A.sub.1c allows for standardization and reporting of units equivalent to % hemoglobin A.sub.1c. Additionally, stable glycated hemoglobin solutions for use as standards in the assay, along with a method for preparing these standards, are disclosed.

Career Highlights

Mary J Annino is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has focused on developing innovative solutions for diabetes care, contributing to advancements in medical technology.

Collaborations

Throughout her career, Mary has collaborated with esteemed colleagues, including Michael D Fiechtner and John M Ramp. These collaborations have further enriched her research and development efforts in the field of glycated hemoglobin testing.

Conclusion

Mary J Annino's contributions to the field of medical diagnostics, particularly in glycated hemoglobin testing, showcase her innovative spirit and dedication to improving patient care. Her patents reflect a commitment to advancing healthcare technology and enhancing the lives of individuals managing diabetes.